Document is current
Any future updates will be listed below
-
Authors
Seiler, Jillian L. https://orcid.org/0000-0003-4430-4797
Impastato, Anna C. https://orcid.org/0000-0001-8919-8313
Zhang, Emma Xiaoyu
Kelley, Kade J. https://orcid.org/0009-0002-9645-3583
Bennett, Thomas L. https://orcid.org/0009-0007-8283-2212
Studnitzer, Bradley
Prindle, Claudia R. https://orcid.org/0009-0008-4111-3550
Rajewski, Benjamin H. https://orcid.org/0000-0002-4750-0331
Badeau, Barry A. https://orcid.org/0000-0002-2247-6646
Jiang, Xinjian
Potterfield, Russell
Delev, Jordan Y. https://orcid.org/0009-0007-9221-1786
Marks, Daniel L. https://orcid.org/0000-0003-2675-7047
- License Information
-
More Information
Article History
Received: 11 November 2025
Accepted: 11 May 2026
First Online: 29 May 2026
Competing interests
: D.L.M. is a consultant, Chief Medical and Scientific Officer, stockholder, and board member of Endevica Bio, Inc., and has received grant funding from the company. D.L.M. is also Chief Medical and Scientific Officer, stockholder, and board member of Kalohexis, Inc., a spinout of Endevica Bio, Inc., and has served as a consultant for Alkermes Inc. and Pfizer Inc. R.P. is Chief Executive Officer, stockholder, and Chair of the Board of Endevica Bio, Inc. and Kalohexis, Inc. J.L.S., A.C.I., E.Z., K.J.K., T.L.B., B.S., C.R.P., B.H.R., B.A.B., and J.Y.D. are employees and stockholders of Endevica Bio, Inc. J.L.S., A.C.I., E.Z., K.J.K., T.L.B., B.S., C.R.P., and B.H.R. are also stockholders of Kalohexis, Inc. B.A.B. and J.Y.D. are stockholders and officers of Kalohexis, Inc. The remaining authors declare no competing interests.
